drugset / Trial / NCT00658684
Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To assess the long term safety, tolerability and efficacy of fesoterodine in patients with OAB.
Timeline
- Start
- 2008-02
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fesoterodine | Other / unclassified | 4 mg | — |
| Subject | Fesoterodine | Other / unclassified | 8 mg | — |